Suppr超能文献

近期传播的B亚型1型人类免疫缺陷病毒变异株对广泛中和抗体的敏感性。

Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.

作者信息

Quakkelaar Esther D, van Alphen Floris P J, Boeser-Nunnink Brigitte D M, van Nuenen Ad C, Pantophlet Ralph, Schuitemaker Hanneke

机构信息

Department of Clinical Viro-Immunology, Sanquin Research and Landsteiner Laboratory of the Academic Medical Center, University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands.

出版信息

J Virol. 2007 Aug;81(16):8533-42. doi: 10.1128/JVI.02816-06. Epub 2007 May 23.

Abstract

The ability of the broadly neutralizing human immunodeficiency virus type 1 (HIV-1) specific human monoclonal antibodies (MAbs) b12, 2G12, 2F5, and 4E10 to neutralize recently transmitted viruses has not yet been explored in detail. We investigated the neutralization sensitivity of subtype B HIV-1 variants obtained from four primary HIV infection cases and six transmission couples (four homosexual and two parenteral) to these MAbs. Sexually transmitted HIV-1 variants isolated within the first 2 months after seroconversion were generally sensitive to 2F5, moderately resistant to 4E10 and b12, and initially resistant but later more sensitive to 2G12 neutralization. In the four homosexual transmission couples, MAb neutralization sensitivity of HIV in recipients did not correlate with the MAb neutralization sensitivity of HIV from their source partners, whereas the neutralization sensitivity of donor and recipient viruses involved in parenteral transmission was more similar. For a fraction (11%) of the HIV-1 variants analyzed here, neutralization by 2G12 could not be predicted by the presence of N-linked glycosylation sites previously described to be involved in 2G12 binding. Resistance to 2F5 and 4E10 neutralization did also not correlate with mutations in the respective core epitopes. Overall, we observed that the neutralization resistance of recently transmitted subtype B HIV-1 variants was relatively high. Although 8 of 10 patients had viruses that were sensitive to neutralization by at least one of the four broadly neutralizing antibodies studied, 4 of 10 patients harbored at least one virus variant that seemed resistant to all four antibodies. Our results suggest that vaccine antigens that only elicit antibodies equivalent to b12, 2G12, 2F5, and 4E10 may not be sufficient to protect against all contemporary HIV-1 variants and that additional cross-neutralizing specificities need to be sought.

摘要

具有广泛中和作用的1型人类免疫缺陷病毒(HIV-1)特异性人单克隆抗体(MAb)b12、2G12、2F5和4E10对近期传播病毒的中和能力尚未得到详细研究。我们调查了从4例原发性HIV感染病例和6对传播伴侣(4对同性恋和2对经肠外途径传播)获得的B亚型HIV-1变体对这些单克隆抗体的中和敏感性。在血清转化后最初2个月内分离出的性传播HIV-1变体通常对2F5敏感,对4E10和b12有中等抗性,并最初对2G12中和有抗性,但后来更敏感。在4对同性恋传播伴侣中,接受者体内HIV的单克隆抗体中和敏感性与其来源伴侣的HIV单克隆抗体中和敏感性不相关,而经肠外途径传播的供体和受体病毒的中和敏感性则更相似。对于此处分析的一部分(11%)HIV-1变体,2G12的中和作用无法通过先前描述的参与2G12结合的N-连接糖基化位点的存在来预测。对2F5和4E10中和的抗性也与各自核心表位的突变无关。总体而言,我们观察到近期传播的B亚型HIV-1变体的中和抗性相对较高。虽然10名患者中有8名患者的病毒对所研究的四种广泛中和抗体中的至少一种敏感,但10名患者中有4名患者携带至少一种似乎对所有四种抗体都有抗性的病毒变体。我们的结果表明,仅引发等同于b12、2G12、2F5和4E10的抗体的疫苗抗原可能不足以预防所有当代HIV-1变体,需要寻找额外的交叉中和特异性。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验